Successful prasugrel rescue therapy in clopidogrel resistant patients who had recurrent stent thrombosis of drug-eluting-stent

The role of prasugrel in clopidogrel nonresponders

Seung Hyun Lee, Byeong Keuk Kim, Jaewon Oh, Jin Su Park, Dong Jun Lee, Han Cheol Lee, Jin Ho Kim, Myeongki Hong

Research output: Contribution to journalArticle

Abstract

Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1%. As the clopidogrel resistance is expected to play an important role in the occurrence of stent thrombosis, new anti-platelet agents overcoming this issue can give us another choice. We experienced a case of a 58-year-old male with successful prasugrel rescue therapy in a patient with clopidogrel resistance who had recurrent stent thrombosis following DES implantation.

Original languageEnglish
Pages (from-to)343-346
Number of pages4
JournalKorean Circulation Journal
Volume43
Issue number5
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

clopidogrel
Drug-Eluting Stents
Stents
Thrombosis
Therapeutics
Blood Platelets
Incidence
Prasugrel Hydrochloride

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Lee, Seung Hyun ; Kim, Byeong Keuk ; Oh, Jaewon ; Park, Jin Su ; Lee, Dong Jun ; Lee, Han Cheol ; Kim, Jin Ho ; Hong, Myeongki. / Successful prasugrel rescue therapy in clopidogrel resistant patients who had recurrent stent thrombosis of drug-eluting-stent : The role of prasugrel in clopidogrel nonresponders. In: Korean Circulation Journal. 2013 ; Vol. 43, No. 5. pp. 343-346.
@article{d66192a5bf8746f49bf612214d3c88dc,
title = "Successful prasugrel rescue therapy in clopidogrel resistant patients who had recurrent stent thrombosis of drug-eluting-stent: The role of prasugrel in clopidogrel nonresponders",
abstract = "Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1{\%}. As the clopidogrel resistance is expected to play an important role in the occurrence of stent thrombosis, new anti-platelet agents overcoming this issue can give us another choice. We experienced a case of a 58-year-old male with successful prasugrel rescue therapy in a patient with clopidogrel resistance who had recurrent stent thrombosis following DES implantation.",
author = "Lee, {Seung Hyun} and Kim, {Byeong Keuk} and Jaewon Oh and Park, {Jin Su} and Lee, {Dong Jun} and Lee, {Han Cheol} and Kim, {Jin Ho} and Myeongki Hong",
year = "2013",
month = "5",
day = "1",
doi = "10.4070/kcj.2013.43.5.343",
language = "English",
volume = "43",
pages = "343--346",
journal = "Korean Circulation Journal",
issn = "1738-5520",
publisher = "Korean Society of Circulation",
number = "5",

}

Successful prasugrel rescue therapy in clopidogrel resistant patients who had recurrent stent thrombosis of drug-eluting-stent : The role of prasugrel in clopidogrel nonresponders. / Lee, Seung Hyun; Kim, Byeong Keuk; Oh, Jaewon; Park, Jin Su; Lee, Dong Jun; Lee, Han Cheol; Kim, Jin Ho; Hong, Myeongki.

In: Korean Circulation Journal, Vol. 43, No. 5, 01.05.2013, p. 343-346.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Successful prasugrel rescue therapy in clopidogrel resistant patients who had recurrent stent thrombosis of drug-eluting-stent

T2 - The role of prasugrel in clopidogrel nonresponders

AU - Lee, Seung Hyun

AU - Kim, Byeong Keuk

AU - Oh, Jaewon

AU - Park, Jin Su

AU - Lee, Dong Jun

AU - Lee, Han Cheol

AU - Kim, Jin Ho

AU - Hong, Myeongki

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1%. As the clopidogrel resistance is expected to play an important role in the occurrence of stent thrombosis, new anti-platelet agents overcoming this issue can give us another choice. We experienced a case of a 58-year-old male with successful prasugrel rescue therapy in a patient with clopidogrel resistance who had recurrent stent thrombosis following DES implantation.

AB - Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1%. As the clopidogrel resistance is expected to play an important role in the occurrence of stent thrombosis, new anti-platelet agents overcoming this issue can give us another choice. We experienced a case of a 58-year-old male with successful prasugrel rescue therapy in a patient with clopidogrel resistance who had recurrent stent thrombosis following DES implantation.

UR - http://www.scopus.com/inward/record.url?scp=84879597637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879597637&partnerID=8YFLogxK

U2 - 10.4070/kcj.2013.43.5.343

DO - 10.4070/kcj.2013.43.5.343

M3 - Article

VL - 43

SP - 343

EP - 346

JO - Korean Circulation Journal

JF - Korean Circulation Journal

SN - 1738-5520

IS - 5

ER -